CLINICAL_TRIALS
trial_result
· 2014-12-02
Clinical Trial Update: A Pilot Study for Ginkgolides Meglumine Injection Skin Testing. [Phase 4]
Summary
A Phase 4 pilot study evaluating skin testing with Ginkgolides Meglumine Injection has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd | Conditions: Allergy | Phase 4 | Status: COMPLETED